Contagion Science explores foundational forces that expose transdisciplinary vulnerabilities of our modern societies and aims to provide a toolkit for response.
The global Covid-19 outbreak put pandemics and pandemic management in the spotlight. Understanding the various factors that influenced its emergence, its evolution, as well as our public health responses offers a multitude of transdisciplinary learning opportunities.
Contagion Science provides an umbrella for fundamental research challenges and acknowledges that mechanisms and patterns of contagion are not limited to pandemics but occur in many areas of our modern societies.
Fueled by a UVA grant of $5 million in support of the University’s quest to move its research from prominence to preeminence, the Contagion Science program provides a coordinated “big science” approach to exploring ways to address contagions of the magnitude we experienced with the global pandemic of the 21st century. Scientists at UVA acknowledge the need to develop cross-cutting technological computing innovations that interface with real-world societal applications to improve planning and response to contagions of this scale and impact. We are eager to find solutions in advance, not if, but when it happens.
Emotion and Behavior Lab
Social contagion involves behavior, emotions, or conditions spreading spontaneously through a group or network. The EB Lab at UVA studies the dynamics and diverse components of social connections and networks.
Pandemic Forecasting and Modeling
The Biocomplexity Institute's approach to pandemic forecasting and modeling supported crucial public health decisions.
Pathogen Genomics Centers of Excellence
A team from the School of Medicine and the Biocomplexity Institute support the CDC as part of a Virginia-based Pathogen Genomics Centers of Excellence.
Together with his team at UVA, Steven Zeichner moves towards the development of a novel HIV Vaccine.
Infectious diseases can significantly impact our societies and economies. What will change look like?
Disaster response requires innovative thinking. UVA engineers leveraged robotics technology in their response.
In the News
Dr. Critchley will leverage her epidemiological training to help explore multidimensionality and highly collinear relationships among social syndemic components of public health data.
Steven Zeichner’s team received a large NIH grant for the development of an HIV vaccine. The approach is specifically designed to yield vaccines that can be produced in existing factories around the world, using extremely low cost, readily available starting materials.
The monthly journal of the Association for Computing Machinery, Communications of the ACM, highlights the underlying technological challenges of pandemic modeling, highlighting - among others - the efforts at the University of Virginia, the Biocomplexity Institute, and the Contagion Science program